Last reviewed · How we verify

CYP2C9 probe

Repros Therapeutics Inc. · Phase 1 active Small molecule

At a glance

Generic nameCYP2C9 probe
Also known asTolbutamide (250 mg)
SponsorRepros Therapeutics Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.